Beta-1 Adrenergic Receptor Neurons

Beta-1 Adrenergic Receptor Neurons

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Beta-1 Adrenergic Receptor Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Adrenergic Receptor Neurons</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Cortex, Hippocampus, Cerebellum, Thalamus</td>
</tr>
<tr>
<td class="label">Receptor Type</td>
<td>β1-AR (ADRB1)</td>
</tr>
<tr>
<td class="label">Signaling</td>
<td>Gs-coupled, excitatory</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>ADRB1 (chromosome 10q24-q26)</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Beta-1 adrenergic receptor</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000109](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000109)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000109](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000109)</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000169](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000169)</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000197](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/

Beta-1 Adrenergic Receptor Neurons

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Beta-1 Adrenergic Receptor Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Adrenergic Receptor Neurons</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Cortex, Hippocampus, Cerebellum, Thalamus</td>
</tr>
<tr>
<td class="label">Receptor Type</td>
<td>β1-AR (ADRB1)</td>
</tr>
<tr>
<td class="label">Signaling</td>
<td>Gs-coupled, excitatory</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>ADRB1 (chromosome 10q24-q26)</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Beta-1 adrenergic receptor</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000109](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000109)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000109](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000109)</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000169](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000169)</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000197](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)</td>
</tr>
</table>

Beta 1 Adrenergic Receptor Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Beta-1 adrenergic receptors (β1-AR, encoded by ADRB1) are excitatory G protein-coupled receptors widely expressed in the central nervous system, particularly in cortical and hippocampal regions. These receptors play critical roles in arousal, attention, learning, memory consolidation, and autonomic regulation. Dysregulation of β1-AR signaling has been implicated in Alzheimer's disease, Parkinson's disease, depression, anxiety disorders, and cognitive impairment following traumatic brain injury. [@odell2013]

Overview

Multi-Taxonomy Classification

Taxonomy Database Cross-References

Morphology & Electrophysiology

• Morphology: adrenergic neuron (source: Cell Ontology)
• Morphology can be inferred from Cell Ontology classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0000109)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000109)
• [OBO Foundry (CL:0000109)](http://purl.obolibrary.org/obo/CL_0000109)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)
• [PanglaoDB](https://panglaodb.se/)

Taxonomy & Classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0000109)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000109)
• [OBO Foundry (CL:0000109)](http://purl.obolibrary.org/obo/CL_0000109)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [PanglaoDB](https://panglaodb.se/)

Molecular Properties

Receptor Structure

The β1-adrenergic receptor is a 7-transmembrane domain GPCR belonging to the adrenergic receptor family. It shares structural homology with β2- and β3-adrenergic receptors but exhibits distinct pharmacological profiles and tissue distribution patterns.

• Family: β-adrenergic receptors (β1, β2, β3)
• G protein: Gs (stimulatory)
• Second messenger: cAMP increases
• Isoforms: Multiple splice variants identified
• Structure: Class A GPCR, 7TM helices

Signaling Pathways

β1-AR activation triggers multiple downstream signaling cascades:

Distribution in the Brain

• Cerebral cortex: High expression in layer 5 pyramidal neurons, particularly in prefrontal cortex (PFC) where β1-AR modulates working memory and executive function
• Hippocampus: Prominent expression in CA1 pyramidal neurons and dentate gyrus granule cells, critical for memory consolidation
• Cerebellum: Expression in Purkinje cells and deep cerebellar nuclei, involved in motor learning and coordination
• Thalamus: Presence in thalamic relay neurons, modulating sensory processing and arousal
• Amygdala: Expression in basal and lateral nuclei, regulating emotional memory and anxiety
• Locus coeruleus: Co-localization with noradrenergic neurons (autoreceptors)

Physiological Functions

Arousal and Attention

β1-AR neurons in the prefrontal cortex and thalamus play essential roles in promoting wakefulness and sustained attention. Noradrenergic projections from the locus coeruleus activate β1-AR in target regions, enhancing signal-to-noise ratio for relevant sensory information and facilitating behavioral responses to salient stimuli [1](https://doi.org/10.1016/j.neuroscience.2008.03.081).

Memory and Learning

The hippocampus exhibits particularly high β1-AR expression, where these receptors are crucial for memory consolidation. β1-AR activation during emotionally arousing experiences enhances memory encoding through:

• CREB-mediated gene transcription
• AMPA receptor trafficking and synaptic strengthening
• Dendritic spine formation
• Consolidation of long-term potentiation (LTP)

Autonomic Regulation

Central β1-AR neurons contribute to sympathetic nervous system control:

• Cardiovascular regulation through hypothalamic and brainstem circuits
• Respiratory control via medullary pathways
• Thermogenesis regulation through brown adipose tissue innervation

Disease Involvement

Alzheimer's Disease

β1-adrenergic receptors play complex roles in Alzheimer's disease pathophysiology:

• Amyloid-β effects: Aβ oligomers can dysregulate β1-AR signaling, leading to impaired cAMP production and reduced CREB activation, contributing to memory deficits
• Noradrenergic degeneration: Loss of locus coeruleus neurons in early AD reduces noradrenergic tone onto β1-AR neurons, exacerbating cognitive decline
• Neuroinflammation: β1-AR activation can modulate microglial activation states, with both protective and detrimental effects depending on disease stage
• Therapeutic potential: β1-AR agonists have shown promise in animal models for enhancing memory and reducing Aβ-induced toxicity, though clinical translation remains challenging [3](https://doi.org/10.1016/j.neurobiolaging.2019.01.012)

Parkinson's Disease

• Motor function: β1-AR in the striatum and motor cortex modulate dopaminergic signaling, and β-adrenergic antagonists can improve levodopa-induced dyskinesias
• Non-motor symptoms: β1-AR dysfunction may contribute to autonomic dysfunction, depression, and cognitive impairment in PD
• Neuroprotection: Emerging evidence suggests β1-AR activation may provide neuroprotective effects against dopaminergic neuron degeneration [4](https://doi.org/10.1016/j.parkreldis.2020.02.015)

Depression and Anxiety

• Depression: Reduced β1-AR signaling is associated with depressive phenotypes. Chronic stress downregulates β1-AR expression in prefrontal cortex and hippocampus
• Antidepressant mechanisms: Many antidepressants (SSRIs, SNRIs, tricyclics) ultimately enhance β1-AR signaling through various mechanisms
• Anxiety: β1-AR in the amygdala and prefrontal cortex regulate anxiety-related behaviors; β1-AR blockade can have anxiolytic effects

Traumatic Brain Injury

Following TBI, β1-AR dysregulation contributes to:

• Impaired memory consolidation
• Autonomic dysfunction
• Increased neuroinflammation
• Secondary excitotoxicity

Therapeutic Implications

β1-AR Agonists

• Dobutamine: Primarily cardiac β1-agonist with limited CNS penetration
• Xamoterol: β1-selective partial agonist investigated for cognitive enhancement
• Research compounds: Novel brain-penetrant β1-agonists under development for AD and cognitive disorders

β1-AR Antagonists

• Metoprolol, Atenolol: β1-selective blockers used for hypertension; potential cognitive effects
• Propranolol: Non-selective β-blocker that can cross the blood-brain barrier; used for anxiety and PTSD memory reconsolidation
• Carvedilol: α1 and β1/2 blocker with neuroprotective properties

Clinical Considerations

• Blood-brain barrier penetration: Critical for CNS effects
• Subtype selectivity: β1 vs. β2 selectivity determines side effect profile
• Timing: Acute vs. chronic administration produces different effects
• Combination therapies: Potential synergy with cholinergic or dopaminergic agents

Research Directions

• Gene therapy: Viral vector-mediated β1-AR overexpression in hippocampal neurons
• Allosteric modulators: Novel positive allosteric modulators with improved selectivity
• Biomarkers: PET ligands for imaging β1-AR density in living brain
• Personalized medicine: β1-AR polymorphisms as predictors of treatment response
• Adrenergic Neurotransmission
• Adrenergic Receptors
• Locus Coeruleus Noradrenergic Neurons
• Beta-2 Adrenergic Receptor Neurons
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

External Links

• [Wikipedia: Adrenergic receptor](https://en.wikipedia.org/wiki/Adrenergic_receptor)
• [IUPHAR/BPS Guide to Pharmacology: β1-adrenoceptor](https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=197)
• [UniProt: ADRB1](https://www.uniprot.org/uniprot/P08588)

Background

The study of Beta 1 Adrenergic Receptor Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Pathway Diagram

The following diagram shows the key molecular relationships involving Beta-1 Adrenergic Receptor Neurons discovered through SciDEX knowledge graph analysis: